Sentry Investment Management LLC decreased its stake in CME Group Inc. (NASDAQ:CME) by 4.5% during the first quarter, according to its most recent 13F filing with the SEC. The fund owned 24,920 shares of the financial services provider’s stock after selling 1,172 shares during the period. Sentry Investment Management LLC’s holdings in CME Group were worth $2,960,000 as of its most recent SEC filing.

Other hedge funds have also modified their holdings of the company. Dynamic Technology Lab Private Ltd acquired a new stake in shares of CME Group during the fourth quarter valued at about $294,000. Pacad Investment Ltd. boosted its stake in shares of CME Group by 4.5% in the fourth quarter. Pacad Investment Ltd. now owns 2,300 shares of the financial services provider’s stock valued at $265,000 after buying an additional 100 shares during the period. Cpcm LLC purchased a new stake in shares of CME Group during the fourth quarter valued at $201,000. Bristol Advisors LLC purchased a new stake in shares of CME Group during the fourth quarter valued at $1,569,000. Finally, Parallel Advisors LLC purchased a new stake in shares of CME Group during the fourth quarter valued at $120,000. 83.55% of the stock is currently owned by institutional investors and hedge funds.

Institutional Ownership by Quarter for CME Group (NASDAQ:CME)

CME Group Inc. (NASDAQ:CME) opened at 124.12 on Monday. The stock has a market capitalization of $42.17 billion, a price-to-earnings ratio of 26.87 and a beta of 0.75. The firm has a 50-day moving average of $119.55 and a 200 day moving average of $119.67. CME Group Inc. has a 52 week low of $92.29 and a 52 week high of $127.74.

CME Group (NASDAQ:CME) last released its quarterly earnings results on Thursday, April 27th. The financial services provider reported $1.22 EPS for the quarter, topping the consensus estimate of $1.20 by $0.02. The firm had revenue of $929 million for the quarter, compared to analyst estimates of $932.06 million. CME Group had a return on equity of 7.43% and a net margin of 43.62%. CME Group’s revenue for the quarter was down .5% on a year-over-year basis. During the same period in the previous year, the company posted $1.15 EPS. On average, analysts anticipate that CME Group Inc. will post $4.87 EPS for the current year.

The business also recently declared a quarterly dividend, which will be paid on Monday, June 26th. Investors of record on Friday, June 9th will be given a dividend of $0.66 per share. This represents a $2.64 annualized dividend and a yield of 2.13%. The ex-dividend date of this dividend is Wednesday, June 7th. CME Group’s dividend payout ratio (DPR) is presently 57.14%.

COPYRIGHT VIOLATION NOTICE: “Sentry Investment Management LLC Lowers Stake in CME Group Inc. (CME)” was reported by The Cerbat Gem and is the sole property of of The Cerbat Gem. If you are accessing this piece of content on another site, it was illegally stolen and reposted in violation of US & international trademark & copyright laws. The original version of this piece of content can be read at https://www.thecerbatgem.com/2017/06/26/sentry-investment-management-llc-lowers-stake-in-cme-group-inc-cme.html.

Several analysts recently weighed in on the stock. Royal Bank Of Canada raised their target price on shares of CME Group from $130.00 to $135.00 and gave the company an “outperform” rating in a report on Tuesday, June 20th. BidaskClub raised shares of CME Group from a “sell” rating to a “hold” rating in a report on Friday. Deutsche Bank AG reduced their target price on shares of CME Group from $137.00 to $134.00 and set a “buy” rating on the stock in a report on Friday, April 28th. Jefferies Group LLC reaffirmed a “buy” rating and issued a $128.00 target price on shares of CME Group in a report on Saturday, March 11th. Finally, Zacks Investment Research raised shares of CME Group from a “sell” rating to a “hold” rating in a report on Monday, March 20th. One analyst has rated the stock with a sell rating, five have issued a hold rating and three have given a buy rating to the company. The company has a consensus rating of “Hold” and a consensus target price of $117.50.

In other CME Group news, Director Dennis Suskind sold 1,099 shares of the company’s stock in a transaction that occurred on Friday, April 28th. The stock was sold at an average price of $115.29, for a total value of $126,703.71. Following the transaction, the director now directly owns 5,000 shares of the company’s stock, valued at approximately $576,450. The sale was disclosed in a filing with the SEC, which is accessible through the SEC website. Also, insider Kathleen M. Cronin sold 8,125 shares of the company’s stock in a transaction that occurred on Wednesday, June 14th. The shares were sold at an average price of $127.35, for a total value of $1,034,718.75. Following the completion of the transaction, the insider now directly owns 38,174 shares in the company, valued at $4,861,458.90. The disclosure for this sale can be found here. Insiders have sold a total of 48,754 shares of company stock worth $5,939,099 over the last three months. 0.61% of the stock is currently owned by corporate insiders.

CME Group Company Profile

CME Group Inc, through its exchanges, provides products across all asset classes, including futures and options based on interest rates, equity indexes, foreign exchange, energy, agricultural products and metals. The Company’s segment primarily consists of the Chicago Mercantile Exchange Inc (CME), Board of Trade of the City of Chicago, Inc (CBOT), New York Mercantile Exchange, Inc (NYMEX) and Commodity Exchange, Inc (COMEX) exchanges.

Receive News & Stock Ratings for CME Group Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CME Group Inc. and related stocks with our FREE daily email newsletter.